Latest Retinitis pigmentosa Stories
Stem cells taken from bone marrow show promise in healing damaged retinal tissue, said researchers at the University of Louisville in Kentucky. The stem cells generated new cells in damaged retinal pigment epithelium, the pigmented cell layer just outside the retina, research led by Dr.
The mystery of genetic disease is only partially solved with the identification of a mutated gene. Often, the pattern of disease â€“ the features or disorders associated with it â€“ vary in type and severity among those who are affected. Scientists, physicians and patients all ask why.
WASHINGTON, April 29 /PRNewswire/ -- Vision loss is a high priority area for VA Research.
Omega three fatty acids protect brain cells by preventing the misfolding of a protein from a gene mutation in Parkinson's disease, U.S. researchers said. Dr. Nicolas Bazan of Louisiana State University and colleagues developed a cell model with a mutation of the Ataxin-1 gene.
Dr. Nicolas Bazan, Director of the Neuroscience Center of Excellence, Boyd Professor, and Ernest C. and Yvette C. Villere Chair of Retinal Degenerative Diseases Research at LSU Health Sciences Center New Orleans,
Experiments with zebra fish are helping identify genes linked to retinal diseases that cause blindness, a Purdue University scientist said. Once we know the genetic network that influences retinal development, we can begin to understand the changes in specific genes that lead to vision loss, Yuk Fai Leung said. With such information, treatments could be developed to prevent or reverse diseases such as macular degeneration and diabetic retinopathy, he said. Using zebra fish, which are closer...
A U.S.-led team of medical researchers says cells isolated from the eye that many scientists believe are retinal stem cells are actually normal adult cells. The international study, led by Michael Dyer of St.
Among zebrafish, the eyes have it. Inside them is a mosaic of light-sensitive cells whose structure and functions are nearly identical to those of humans.
VANCOUVER, March 12 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced the results from a Phase Ia trial of QLT091001 in healthy adult volunteers.
Montreal March 2nd, 2009 â€“ The team of Dr. Robert Koenekoop which includes Dr. Irma Lopez from the Research Institute of the MUHC at the Montreal Children's Hospital played a crucial role in the international collaboration that led to the discovery of a new gene that causes Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP), two devastating forms of childhood blindness.